I spent nearly fifty years living with severe headaches and occasional migraine attacks, starting in childhood. What began as an almost constant underlying headache, punctuated by severe episodes, followed me through my teenage years and into adulthood. Several of those migraine attacks were serious enough to require hospitalization. I moved through nearly every treatment available along the way — aspirin, then Excedrin, then prescription migraine medications, eventually narcotics, and at one point I was seriously considering Botox injections. One episode in particular lasted for days and simply would not respond to anything doctors tried. I’m not writing this article as an outside observer describing a condition I’ve read about. I lived inside it for most of my life.
This isn’t a small story. According to the World Health Organization, headache disorders affect roughly 40 percent of the global population, and migraine specifically ranks as the third-highest cause of disability-adjusted life years worldwide. That’s not a niche complaint. That’s tens of millions of people whose work, relationships, and daily functioning are shaped by a condition that, for decades, medicine had very little targeted to offer.
What follows is a grounded look at where things actually stand in 2026 — what the newer treatments do, what the evidence supports and doesn’t, and why the unglamorous basics (sleep, hydration, consistency) still carry real weight even in an era of targeted biologics. A few years ago, correcting a chronic electrolyte imbalance, particularly around magnesium, eliminated my own migraines and headaches almost entirely after decades of searching. I discuss the broader evidence and practical context in Magnesium: The Invisible Deficiency Behind Anxiety, Migraines, and Poor Sleep. That’s my experience, not a claim that it will work identically for everyone — migraine has too many different underlying mechanisms for any single fix to be universal. But it’s exactly why I take both sides of this seriously: the real, evidence-backed medical treatments available today, and the foundational, unglamorous factors that too often get dismissed as “just drink more water.” I’ve been failed by both extremes of that conversation at different points in my life.
What Changed With CGRP-Targeted Treatment
For decades, many migraine preventives were medications borrowed from other fields: blood-pressure drugs, anti-seizure medications, and antidepressants that happened to reduce attacks for some people. The arrival of treatments aimed specifically at calcitonin gene-related peptide (CGRP), a signaling molecule involved in migraine biology, changed that landscape. CGRP-targeted options now include injectable or infused monoclonal antibodies used for prevention and oral small-molecule CGRP receptor antagonists called gepants, some of which are used acutely, preventively, or both depending on the specific drug.
The important point is not that CGRP treatment has made older options obsolete. It has given clinicians another evidence-based class developed around migraine biology. In August 2026, the American Headache Society and American Academy of Neurology published an updated adult migraine-prevention guideline and accompanying systematic review, replacing a prevention guideline that dated back to 2012. The newer evidence base includes CGRP-targeted therapies alongside established preventive medications.
Acute Treatment and Prevention Are Different Jobs
Acute treatment is meant to stop or reduce an attack that has already started. Depending on the person and diagnosis, that may involve a simple analgesic, a triptan, a gepant, an anti-nausea medication, or another migraine-specific strategy. Preventive treatment has a different goal: reducing how often attacks occur, how severe they are, or how much they disrupt life over time.
Someone can need both. A person may have an effective rescue medication and still have enough migraine days or disability to justify prevention. Conversely, preventive treatment does not guarantee that an acute option will never be needed.
CGRP Monoclonal Antibodies and Gepants
CGRP monoclonal antibodies are larger biologic molecules designed to target CGRP itself or its receptor. They are generally given by injection, with one option administered by infusion. Their role is primarily preventive. Gepants are smaller oral molecules that block the CGRP receptor. The class includes drugs used for acute attacks and drugs used for prevention, with some agents having more than one approved role.
These treatments are not interchangeable simply because they share a pathway. Dosing schedules, indications, side-effect profiles, interactions, insurance coverage, pregnancy considerations, and individual response differ. Post-marketing safety surveillance continues to add information beyond what the original clinical trials could capture. The useful comparison is which evidence-supported option fits a particular person’s migraine pattern, medical history, previous treatment response, and priorities.
Established Options Still Matter
Targeted treatment did not erase the usefulness of older therapies. Depending on the migraine pattern and the person, preventive options can still include certain beta blockers, anti-seizure medications, antidepressants, onabotulinumtoxinA for chronic migraine, and other established medications. Acute treatment can include triptans and other non-CGRP options. Some people respond extremely well to an older, inexpensive medication; others reach CGRP treatment after several approaches fail or produce unacceptable adverse effects.
Medication Overuse Is Still Part of the Conversation
More treatment choices do not eliminate an old migraine problem: frequent use of acute headache medication can itself contribute to medication-overuse headache. The risk and frequency threshold are not identical for every drug class, so this is something to discuss specifically with the clinician managing recurrent headaches rather than applying one generic limit to every medication.
If acute medication is needed repeatedly, that is also a reason to revisit the overall treatment plan. It may indicate that prevention, diagnosis, triggers, another headache disorder, or the current rescue strategy deserves another look.
What Still Matters at Home
The existence of targeted biologics does not make the basics irrelevant. Migraine can be sensitive to disruptions in routine. Regular sleep, adequate hydration, consistent meals, appropriate physical activity, and learning individual patterns can all matter. A headache diary can be more useful than trying to memorize every possible “trigger” listed online because it helps distinguish a recurring personal pattern from coincidence.
These measures should not be framed as a cure or as proof that someone caused their own migraine by living incorrectly. Migraine is a neurological disorder. Lifestyle consistency is one part of management, not a moral test and not a replacement for effective medical treatment.
Where Magnesium Fits
Magnesium has been studied in migraine and is included in many discussions of nonprescription prevention, but that does not mean every person with migraine is magnesium deficient or that supplementation will reproduce my experience. My own improvement after addressing electrolyte balance was dramatic, which is why I talk about it. It remains one person’s experience. Anyone considering magnesium should account for kidney function, medications, gastrointestinal tolerance, and the actual amount of elemental magnesium being used. I cover the evidence and limitations separately in Magnesium: The Invisible Deficiency Behind Anxiety, Migraines, and Poor Sleep.
When a Headache Needs Urgent Evaluation
A familiar migraine pattern is different from a new or dramatically changed headache. Seek urgent medical evaluation for a sudden severe headache that reaches maximum intensity rapidly; headache after a significant head injury; headache accompanied by new weakness, numbness, difficulty speaking, confusion, fainting, seizure, or major vision change; or a severe new headache with fever and neck stiffness. New headache patterns during pregnancy or postpartum, or a major change in headaches later in life, also deserve prompt medical assessment.
Questions Worth Taking to a Migraine Appointment
- Am I treating the correct headache diagnosis, or could more than one headache disorder be present?
- Based on my number of migraine days and disability, should we discuss preventive treatment?
- What are the advantages and disadvantages of a CGRP-targeted option for my medical history compared with established preventives?
- Is the frequency of my acute medication use putting me at risk for medication-overuse headache?
- Which symptoms would mean this is no longer my usual migraine and needs urgent evaluation?
- What should we track over the next few months to decide whether a treatment is actually working?
The Bottom Line
Migraine care in 2026 is materially different from the care available for much of my life. CGRP-targeted treatments have expanded both acute and preventive options, and the evidence base for prevention has now been reassessed in a major 2026 guideline. But “new” does not automatically mean “best for everyone,” and older therapies have not suddenly stopped working.
The useful shift is choice: better-targeted medications when they fit, established therapies when they fit, and everyday management that reduces avoidable strain without pretending migraine can be lifestyle-hacked away. For someone who has lived with severe headaches for decades, that is a much better place for the field to be.
Sources & Further Reading
- American Headache Society — Clinical Practice Guidelines — includes the 2026 adult migraine-prevention practice guideline and systematic review.
- American Headache Society — Updated Guideline on Migraine Prevention Medications for Adults.
- World Health Organization — Migraine and Other Headache Disorders.
Disclaimer
Content on Real David Julian is provided for educational and informational purposes and may include research-based discussion, personal experience, and opinion. It is not medical advice and is not a substitute for individualized care from a qualified healthcare professional. Always discuss your specific health needs, diagnoses, medications, supplements, treatments, or major health decisions with an appropriate healthcare professional. See the full Disclaimer for additional information.